EAM Investors’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-39
Closed -$605K 238
2019
Q2
$605K Hold
39
0.15% 234
2019
Q1
$653K Buy
+39
New +$653K 0.16% 232